So, there was a lot of conference coverage and interesting diabetes discussion coming out of the recent ADA Scientific Sessions. We enjoyed being able to mix with the experts on D-research and treatment. But those of us living with diabetes have our own perspective, of course. Not least was observing some striking ironies that materialized in many corners of the convention center and downtown Philly. For example:
- Despite her supposedly acting as the face of Novo's Victoza medication for type 2s, Paula Deen's smiling face was conspicuously absent from anywhere in the company's restaurant-sized booth on the exhibit hall floor.
- Our friend Dayle Kern, one-time-communications-employee of the ADA and a type 1 herself tweeted, "Had a low blood glucose of 53 while hearing about research on hypoglycemia & the brain. #ironic?"
- I had one of those, too... Going down to 49 mg/dL in a session talking about CGMs helping to prevent lows; my CGM alert started beeping loudly right there during the session, thanks to my ignoring the vibration at my belt-line.
- During a morning session about why patients don't log their data enough, I mused on the fact that I rarely track my BGs in paper logbook or by device download, but always log my #bgnow via Twitter. And I even did that from the very session!
- Amy always rolls her eyes at the smoothie stands several vendors set up in their expo booths, often right across from the booths where you can get your A1C tested for free. Pure fructose drink, anyone?!
- Our friend and fellow PWD Catherine Price from A Sweet Life tweeted this: "There is a certain irony to sitting in a lecture about how sitting too much can kill you."
- We loved how fellow diabetes advocate and blogger Kelly Kunik, covering the conference for Roche Accu-Chek, snapped this ironic photo observation from her hotel room. Cool marketing idea, we suppose...
American Diabetes Association Names New CEO
Non-profit leader Kevin L. Hagan named as new chief exec of national diabetes org after six-month search.
FDA Approves New Basal Insulin
Sanofi's Troujeo has 'flatter profile' of action that helps to avoid lows.
Daytona Win for Racecar Driver with Diabetes!
Type 1 driver Ryan Reed wins first NASCAR series race at Daytona on Feb. 21.
- Fellow journalist and longtime PWD Miriam Tucker, who's attended 24 of these Scientific Sessions through the years, found it ironic to see all the diabetes experts taking shuttle buses just a few short blocks, standing still on the escalators, and so on. You know, in the middle of a conference where so many of them preach about the need for more activity and exercise.
A few more sour ironies:
- Much talk on the ADA's position statement on "patient-centered care," which was revised earlier this year, and came up many times at this huge conference that really isn't patient-centered or directed at the patient's frame of reference.
- Endo and D-Blogger Dr. Bill Quick, who's also a fellow PWD, found it ironic that the ORIGIN study was hailed as such a success the way it was when, in fact, the study failed more than a decade ago and didn't end up proving the original hypothesis. He describes the study's title as "lipstick on a pig," because it was initially designed to prove that basal insulin decreased cardiovascular risk but ended up not showing that at all.
Did you attend and see or experience any ironies? How about those of you watching or reading about the conference from a distance? Anything strike you as "off"?